Is XORTX Therapeutics Inc halal to invest in?

As of July 2026, XORTX Therapeutics Inc XRTX.NE is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.

Is XORTX Therapeutics Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes XORTX Therapeutics Inc using these criteria to determine its compliance status.

Can Muslims buy shares of XORTX Therapeutics Inc?

Muslim investors may consider investing in XORTX Therapeutics Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is XORTX Therapeutics Inc classified as NOT HALAL?

Musaffa determines the Shariah status of XORTX Therapeutics Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for XORTX Therapeutics Inc updated?

The Shariah compliance status of XORTX Therapeutics Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like XORTX Therapeutics Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of XORTX Therapeutics Inc?

You can check the latest Shariah compliance status of XORTX Therapeutics Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

XORTX Therapeutics Inc XRTX.NE

Last Updated: May 11, 12:00 AM·NEO

XRTX.NE Shariah Compliance

Screening Methodology: AAOIFI

As of July 2026, XORTX Therapeutics Inc is classified as not halal.

NOT HALAL

Report Source: 2026 1st Quarter Report

XORTX Therapeutics Inc. Stock Analysis XRTX.NE

Canada Health Care Nano Cap Report: Q1, 2026

XORTX Therapeutics, Inc. is a biopharmaceutical company. The firm is engaged in developing medications that improve the quality of life and health of individuals with gout and other important diseases. The company has three clinically advanced products in development: its lead program, XRx-026 program for the treatment of gout; XRx-008 program for autosomal dominant polycystic kidney disease (ADPKD); and XRx-101 for acute kidney and other acute organ injury associated with respiratory virus infections. In addition, the Company is developing XRx-225, a pre-clinical stage program for Type II diabetic nephropathy. The company is working to advance products that target aberrant purine metabolism and xanthine oxidase to decrease or inhibit the production of uric acid. The XRx-026 program is designed to decrease the chronically high serum uric acid concentration in the blood (SUA) by inhibiting the production of uric acid by the xanthine oxidase enzyme by administering a xanthine oxidase inhibitor-oxypurinol.

Key Statistics of XORTX Therapeutics Inc (XRTX.NE)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

CAD3.31CAD3.31

Today's Open

CAD3.31

Volume

100.00

P/E Ratio (TTM)

Financial Metrics & Statements of XORTX Therapeutics Inc (XRTX.NE)

Super Investors Invested in XORTX Therapeutics Inc (XRTX.NE)

FAQ's for XORTX Therapeutics Inc (XRTX.NE)

As of July 2026, XORTX Therapeutics Inc XRTX.NE is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes XORTX Therapeutics Inc using these criteria to determine its compliance status.
Muslim investors may consider investing in XORTX Therapeutics Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
Musaffa determines the Shariah status of XORTX Therapeutics Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
The Shariah compliance status of XORTX Therapeutics Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
You can check the latest Shariah compliance status of XORTX Therapeutics Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.